@Bilked2TheBrink I attached this info, and about six other posts covering CT's, ODPRN, & falsified data, and they've all disappeared! Twit keeps shutting me down.
RT @PainSteals: @Bilked2TheBrink "Clinical Trial Run-In Period": Allows manipulation of CT's by excluding participants who respond to drug…
@Bilked2TheBrink "Clinical Trial Run-In Period": Allows manipulation of CT's by excluding participants who respond to drug in a way that would negatively impact Trial outcome & FDA approval. Rosuvastatin: 73.5% had severe muscle pain & dropped out,
"Clinical Trial Run-In Period": Allows manipulation of CT's by excluding participants who respond to drug in a way that would negatively impact Trial outcome & FDA approval. Rosuvastatin: 73.5% had severe muscle pain & dropped out, so didn't count
@Bilked2TheBrink "Clinical Trial Run-In Period": Allows manipulation of CT's by excluding participants who respond to the drug in a way that would negatively impact Trial outcome & FDA approval. Rosuvastatin: 73.5% had severe muscle pain & dropped
@SteZhao @EpiEllie @jon_y_huang @kaz_yos 1/ I don't know much about run-in periods, but I found a paper by my soon-to-be-boss Asbjørn Hróbjartsson (https://t.co/Y7R7y1Hs3J). After reading this, my intuition is that there are aspects of this that you can em
@VPrasadMDMPH @dlandre @DaveKeto And more likely to be used in industry-sponsored trials: https://t.co/ftT2AXgdpQ
Ensaios clínicos randomizados com períodos de run-in: frequência, características e relato. Leia em https://t.co/t3veMoiSLO